ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Free Report)’s stock price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $54.08 and traded as low as $52.40. ProShares Ultra Nasdaq Biotechnology shares last traded at $55.13, with a volume of 14,819 shares trading hands.
ProShares Ultra Nasdaq Biotechnology Stock Performance
The firm has a 50-day moving average price of $54.09 and a 200-day moving average price of $60.71.
ProShares Ultra Nasdaq Biotechnology Increases Dividend
The company also recently announced a dividend, which was paid on Tuesday, December 31st. Shareholders of record on Monday, December 23rd were issued a $0.3964 dividend. This is a boost from ProShares Ultra Nasdaq Biotechnology’s previous dividend of $0.15. The ex-dividend date of this dividend was Monday, December 23rd.
Institutional Trading of ProShares Ultra Nasdaq Biotechnology
ProShares Ultra Nasdaq Biotechnology Company Profile
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.
Featured Articles
- Five stocks we like better than ProShares Ultra Nasdaq Biotechnology
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Bloom Energy: Powering the Future With Decentralized Energy
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- How to Choose Top Rated Stocks
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.